Net Visual Results

Net Visual Results (NVR) was a specialized clinical research organization (CRO) that provided digital imaging core laboratory services to the pharmaceutical, biotechnology, and medical device industries. The company focused on the centralized management and analysis of medical images in clinical trials, utilizing proprietary software to streamline the collection, quality control, and independent review processes. NVR's solutions were designed to improve the accuracy and efficiency of imaging endpoints in global clinical studies across various therapeutic areas, including oncology and cardiology. In December 2013, the company was acquired by CardioNet (later renamed BioTelemetry), which was subsequently acquired by Royal Philips in 2021. NVR's capabilities have since been integrated into the Philips clinical trial imaging portfolio.